Risa Stack, PhD
Chair & Director
Most recently, Risa led the New Business Creation team at GE Ventures which started companies in healthcare, energy, and software. The team has launched Evidation Health, Vineti, Menlo Microsystems, Drawbridge Health, Avitas, and AiROXS.
Risa joined the GE Ventures team from Kleiner Perkins Caufield & Byers where she was a partner for 10 years. While at Kleiner Perkins Caufield & Byers, Risa incubated several companies and was the founding CEO of two. Risa has invested in and held board director or observer roles in over a dozen healthcare companies including: Corthera (acquired by Novartis), Epizyme (NASDAQ: EPZM), Foundation Medicine (NASDAQ:FMI), Ilex Oncology (acquired by Genzyme), Orexigen (NASDAQ:OREX), Pacific Biosciences (NASDAQ:PACB), Triangle Pharmaceuticals (acquired by Gilead), Trius (acquired by Cubist), and Veracyte (NASDAQ:VCYT).
Risa holds a degree in genetics and development with distinction from the University of Illinois, a PhD in immunology from the University of Chicago, and was a member of the second class of Kauffman Fellows.
